Lipid Species Offer Insights into Metabolic Health
By LabMedica International staff writers Posted on 11 Jul 2018 |
Image: The Accela liquid chromatography system (Photo courtesy of Thermo Fisher Scientific).
Heart disease is the number one killer in the USA, and high triglyceride levels in the blood are cited as just one of several risk factors. Millions of lipid panels, blood tests that look at cholesterol levels as well as triglycerides, are performed in clinics each year.
Aberrant levels of storage lipids (triacylglycerol [TAG]), circulating lipid-protein complexes (lipoprotein particles), and membrane lipids (phospholipids [PL] and diacylglycerols [DAG]) have been linked to metabolic dysfunction, such as seen in the metabolic syndrome, whose features include obesity, insulin resistance, cardiovascular diseases, and non-alcoholic liver disease (NAFLD).
Scientists at the Morgridge Institute for Research (Madison, WI, USA) and their international colleagues enrolled 29 males and 15 females and used a murine model in a study of individual species of triglycerides. Fasting whole blood samples were obtained by venipuncture after an overnight fast of eight hours or more and processed for plasma within two hours on the day of liver biopsy. Routine blood tests were performed at a university hospital and included measures of alanine transaminase (ALT), aspartate transaminase (AST), fasting TAG, cholesterol, glucose and insulin.
The biochemical tests were performed according to the manufacturer instructions for each parameter. Liquid chromatography–mass spectrometry (LC-MS) analysis was performed on an Ascentis Express C18 column using an Accela LC Pump (400 μL/min flow rate.
The team found quantitative trait loci (QTLs) for ∼94% of the lipids measured. Several QTLs harbored genes associated with blood lipid levels and abnormal lipid metabolism in human genome-wide association studies. Lipid species from different classes provided signatures of metabolic health, including seven plasma triglyceride species that associated with either healthy or fatty liver. This observation was further validated in an independent mouse model of non-alcoholic fatty liver disease (NAFLD) and in plasma from NAFLD patients. This work provides a resource to identify plausible genes regulating the measured lipid species and their association with metabolic traits.
Molly McDevitt, BS, a graduate student and co-first author of the study, said, “We don't even know how many different triglycerides there are – hundreds, thousands. We found that some triglycerides correlate positively with a fatty liver, while others correlate negatively with a fatty liver. Lumping all triglycerides into one class masks these subtler associations.” The study was published on June 13, 2018, in the journal Cell Systems.
Related Links:
Morgridge Institute for Research
Aberrant levels of storage lipids (triacylglycerol [TAG]), circulating lipid-protein complexes (lipoprotein particles), and membrane lipids (phospholipids [PL] and diacylglycerols [DAG]) have been linked to metabolic dysfunction, such as seen in the metabolic syndrome, whose features include obesity, insulin resistance, cardiovascular diseases, and non-alcoholic liver disease (NAFLD).
Scientists at the Morgridge Institute for Research (Madison, WI, USA) and their international colleagues enrolled 29 males and 15 females and used a murine model in a study of individual species of triglycerides. Fasting whole blood samples were obtained by venipuncture after an overnight fast of eight hours or more and processed for plasma within two hours on the day of liver biopsy. Routine blood tests were performed at a university hospital and included measures of alanine transaminase (ALT), aspartate transaminase (AST), fasting TAG, cholesterol, glucose and insulin.
The biochemical tests were performed according to the manufacturer instructions for each parameter. Liquid chromatography–mass spectrometry (LC-MS) analysis was performed on an Ascentis Express C18 column using an Accela LC Pump (400 μL/min flow rate.
The team found quantitative trait loci (QTLs) for ∼94% of the lipids measured. Several QTLs harbored genes associated with blood lipid levels and abnormal lipid metabolism in human genome-wide association studies. Lipid species from different classes provided signatures of metabolic health, including seven plasma triglyceride species that associated with either healthy or fatty liver. This observation was further validated in an independent mouse model of non-alcoholic fatty liver disease (NAFLD) and in plasma from NAFLD patients. This work provides a resource to identify plausible genes regulating the measured lipid species and their association with metabolic traits.
Molly McDevitt, BS, a graduate student and co-first author of the study, said, “We don't even know how many different triglycerides there are – hundreds, thousands. We found that some triglycerides correlate positively with a fatty liver, while others correlate negatively with a fatty liver. Lumping all triglycerides into one class masks these subtler associations.” The study was published on June 13, 2018, in the journal Cell Systems.
Related Links:
Morgridge Institute for Research
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans